MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinsonism"

  • 2022 International Congress

    Asymmetric midbrain atrophy in a patient with progranulin-related FTLD

    A. Ameri, A. Mahajan, M. Rosenbaum, L. Verhagen Metman (Chicago, USA)

    Objective: We describe an atypical imaging finding in a patient with corticobasal syndrome (CBS) and a genetic diagnosis of frontotemporal lobar dementia (FTLD) associated with…
  • 2022 International Congress

    Cognition in parkinson disease: Tunisian clinical experience

    F. Syrine, B. Nadia, H. Hela, F. Saloua, B. Mariem, FRE. Mohamed (tunis, Tunisia)

    Objective: In this study, we identified among Parkinson Disease patients those pre-disposed to cognitive impairment, and described their clinical profiles. Background: Parkinson disease (PD) is…
  • 2022 International Congress

    Parkinsonism-hyperpyrexia as a rare consequence of deep brain stimulator malfunction in patients with Parkinson’s disease

    M. Castela, M. Estrada, S. Bruck, E. San Martín, J. álvarez, C. Fernández, J. Carriles, B. Aragoneses, A. Ayala, E. Liébana, B. López, J. Gil, A. Antón, P. Arroyo, AK. Mendoza (Oviedo, Spain)

    Objective: To report two cases of parkinsonism-hyperpyrexia secondary to failure of the deep brain stimulator (DBS) of the subthalamic nucleus (STN) in patients with Parkinson's…
  • 2022 International Congress

    Programming Time and the Use of a Visualization Tool for DBS Programming of a Multiple­-Source, Constant-Current System

    J. Aldred, T. Zesiewicz, M. Okun, J. Ramirez-Castaneda, L. Verhagen-Metman, C. Luca, R. Ramdhani, J. Durphy, Y. Bezchlibnyk, K. Foote, S. Sani, A. Papanastassiou, J. Carlson, J. Jagid, D. Weintraub, J. Piltitsis, Y. Pei, R. Jain (Spokane, USA)

    Objective: To describe utilization of image-guided programming for use as a deep brain stimulation (DBS) planning tool during initial device programming in a cohort of…
  • 2022 International Congress

    Worse Sleep Quality Aggravates the Motor and Non-Motor Symptoms in Parkinson’s Disease

    Y. Qu, YP. Chen, L. Li, JY. Li, QX. Qin, DL. Wang, JW. Zhao, ZJ. Mao, YJ. Xiong, Z. Min, Z. Xue (Wuhan, China)

    Objective: The current study aims to investigate the association of sleep characteristics with motor and non-motor dysfunctions of Parkinson’s disease (PD) in a single-center, observational,…
  • 2022 International Congress

    Parkinsonian disorders may have different pain features.

    SY. Kang, YH. Sung (Hwaseong, Republic of Korea)

    Objective: The aim of this study was whether the pain is a unique feature of Parkinson's disease, which precedes motor symptoms, and its characteristics would…
  • 2022 International Congress

    ASYMMETRIC EARLY-ONSET PARKINSONISM DUE TO PSEN1 MUTATION

    E. Luque-Buzo, J. Pérez Sáchez, M. Gonzalez-Sanchez, A. Contreras-Chicote, S. Secades, B. Casa-Fages, F. Grandas (Madrid, Spain)

    Objective: To report a novel case of early-onset parkinsonism due to a presenilin 1 gene (PSEN1) mutation. Background: Mutations in PSEN1 gene are the most…
  • 2022 International Congress

    Development of C-terminal α-Synuclein Vaccine for Treatment and Prevention of Parkinson’s Disease and Other Synucleinopathies

    R. Barbour, A. Elmaarouf, L. Louie, S. Tam, C. Tourino, B. Campbell, G. Kinney, W. Zago (South San Francisco, USA)

    Objective: Prothena is developing active vaccine candidates targeting α-synuclein (α-syn) epitopes shown in clinical and/or preclinical studies to disrupt synuclein pathology. These vaccines, which target…
  • 2022 International Congress

    Assessment of cognitive functions and gait in PD and ET patients with pharmacoresistant tremor treated with Gamma Knife thalamotomy.

    M. Figura, L. Milanowski, K. Sadowski, A. Korn, A. Ziobro, D. Koziorowski (Warsaw, Poland)

    Objective: The aim of our study was to assess the impact of unilateral Gamma Knife thalamotomy on gait and balance and well as psychological functioning…
  • 2022 International Congress

    Alpha-synuclein fibril-based mouse model of REM sleep behavior disorder as a prodrome of synucleinopathy

    HS. Yoo, R. Luke, C. Durso, Y. Liang, J. Steltz, D. Chernoff, B. Zhang, KH. Hoxha, B. Dugan, JJ. Fraigne, W. O’Brien, J. Peever, K. Luk (Seoul, Republic of Korea)

    Objective: To investigate whether in wild-type mice, inoculation of α-synuclein (aSyn) preformed fibrils (PFFs) into the sublaterodorsal tegmental nucleus (SLD), a core structure associated with…
  • « Previous Page
  • 1
  • …
  • 54
  • 55
  • 56
  • 57
  • 58
  • …
  • 405
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Life expectancy with and without Parkinson’s disease in the general population
  • #25111 (not found)
  • Effect of marijuana on Essential Tremor: A case report
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley